These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7945126)

  • 21. Ginger root against seasickness. A controlled trial on the open sea.
    Grøntved A; Brask T; Kambskard J; Hentzer E
    Acta Otolaryngol; 1988; 105(1-2):45-9. PubMed ID: 3277342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Habituation of seasickness in adult during a long voyage].
    Li JR; Zhu L; Yuan W; Jin GR; Sun JJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):642-5. PubMed ID: 23141394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
    Kalimo K; Jansen CT
    Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea.
    Hershkovitz D; Asna N; Shupak A; Kaminski G; Bar R; Tal D
    Aviat Space Environ Med; 2009 Jul; 80(7):643-6. PubMed ID: 19601507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of transdermal scopolamine against seasickness: a 3-day study at sea.
    Attias J; Gordon C; Ribak J; Binah O; Rolnick A
    Aviat Space Environ Med; 1987 Jan; 58(1):60-2. PubMed ID: 3814034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combined effect of cinnarizine and domperidone on vestibular susceptibility.
    Oosterveld WJ
    Aviat Space Environ Med; 1987 Mar; 58(3):218-23. PubMed ID: 3495259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End-tidal CO
    Hasegawa T; Oe H; Taki M; Sakaguchi H; Hirano S; Wada Y
    Auris Nasus Larynx; 2017 Oct; 44(5):534-539. PubMed ID: 27986366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Republic of Singapore Navy's Scopoderm TTS study: results after 2,200 man-days at sea.
    How J; Lee PS; Seet LC; Tan PK
    Aviat Space Environ Med; 1988 Jul; 59(7):646-50. PubMed ID: 3044323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a portable acustimulation device in controlling seasickness.
    Bertolucci LE; DiDario B
    Aviat Space Environ Med; 1995 Dec; 66(12):1155-8. PubMed ID: 8747609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness.
    Warwick-Evans LA; Masters IJ; Redstone SB
    Aviat Space Environ Med; 1991 Aug; 62(8):776-8. PubMed ID: 1930060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic Versus Antihistaminic Treatment for Simulator Sickness Prevention.
    Ben-Ari O; Sarfati S; Gordon B; Assa A; Nakdimon I
    J Clin Pharmacol; 2023 Oct; 63(10):1119-1125. PubMed ID: 37491788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seasickness susceptibility, personality factors, and salivation.
    Gordon CR; Ben-Aryeh H; Spitzer O; Doweck I; Gonen A; Melamed Y; Shupak A
    Aviat Space Environ Med; 1994 Jul; 65(7):610-4. PubMed ID: 7945127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promethazine as a motion sickness treatment: impact on human performance and mood states.
    Cowings PS; Toscano WB; DeRoshia C; Miller NE
    Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of seasickness and its consequences by a method of peer evaluation.
    Gal R
    Aviat Space Environ Med; 1975 Jun; 46(6):836-9. PubMed ID: 1156293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of cinnarizine on various types of vertigo. Clinical and electronystagmographic results of a double-blind study].
    Hausler R; Sabani E; Rohr M
    Acta Otorhinolaryngol Belg; 1989; 43(2):177-85. PubMed ID: 2690563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenytoin as a countermeasure for motion sickness in NASA maritime operations.
    Woodard D; Knox G; Myers KJ; Chelen W; Ferguson B
    Aviat Space Environ Med; 1993 May; 64(5):363-6. PubMed ID: 8503807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postural dynamics and habituation to seasickness.
    Tal D; Bar R; Nachum Z; Gil A; Shupak A
    Neurosci Lett; 2010 Jul; 479(2):134-7. PubMed ID: 20493235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.